Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Compound 28 is a new quinoxaline-2,3-dione derivative synthesized from N-[2,3-dioxo-6-(phenylethynyl)-3,4-dihydroquinoxalin-1(2H)-yl] benzamide as a lead structure, which is a competitive GluK3 antagonist with sub-micromolar affinity and unprecedentedly high binding selectivity, with 400-fold higher selectivity for GluK3 than for other cognate receptors, and no agonistic or antagonistic activity in mGluRs isoforms [186]
If you are seriously evaluating GLP-1 alternatives, you should not just ask, What works for a few months? You should ask, What still works years later? For many qualified patients, gastric sleeve is the better answer
Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients
Ozempic and Vision: Understanding the Eye Health Implications of GLP-1 Medications Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Chris Dunnington Published: September 2, 2025 Last Updated: May 1, 2026 The remarkable rise in popularity of semaglutide medications, particularly Ozempic and Wegovy, has transformed diabetes and weight management treatment
US$ 26.94
US$ 20.12
US$ 23.36
US$ 25.81
